Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer

Grant A. Howe(University of Ottawa), Christina Addison(University of Ottawa)
PLoS ONE
March 10, 2016
Cited by 39


Related Papers